在深度大脑刺激后,帕金森病患者的运动网络的重组
Bei Luo1, Lei Chang1, Chang Qiu1
1Department of Functional Neurosurgery, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
CNS neuroscience & therapeutics
|June 13, 2024
概括
帕金森病 (PD) 的深度大脑刺激 (DBS) 通过微损伤效应在刺激之前引起运动改善. 这项研究揭示了运动网络中功能连接性显著下降,为PD治疗提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 医疗成像医学成像
背景情况:
- 帕金森病 (PD) 患者在深度大脑刺激 (DBS) 后甚至在刺激开始之前,通常会显示出运动症状的改善,这种现象被称为微损伤效应.
- 在PD中这种微损伤效应的潜在神经生物学机制仍然不完全理解.
研究的目的:
- 为了研究PD患者在微损伤阶段与运动功能相关的大脑区域的功能连接性 (FC) 变化.
- 利用基于种子的FC分析来探索DBS手术前后大脑网络的变化.
主要方法:
- 休息状态功能磁共振成像 (fMRI) 数据从49名PD患者获得了DBS手术前和后 (无刺激) 的数据.
- 基于种子的FC分析使用与运动相关的皮质和皮质下大脑区域进行.
- 研究了FC变化和电机尺度得分之间的相关性.
主要成果:
- 在DBS手术后,在运动网络内观察到功能连接的显著下降.
- 显示FC减少的特定区域包括左侧中旋,双侧中前旋,右侧补充运动区域,左侧前中心旋,左侧后中心旋,左侧下额头旋和右侧上额头旋.
- 分析了这些FC变化与运动症状尺度的关系.
结论:
- 与PD中DBS相关的微损伤效应涉及与运动相关的大脑网络的实质性重组.
- 这些发现为DBS如何增强帕金森病患者的运动功能提供了新的网络层面的见解.
相关概念视频
Parkinson's Disease: Treatment
257
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
257
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Overview
527
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
527


